Home/Filings/4/0001654954-22-015598
4//SEC Filing

Oki Mark K 4

Accession 0001654954-22-015598

CIK 0001385818other

Filed

Nov 20, 7:00 PM ET

Accepted

Nov 21, 9:30 AM ET

Size

4.4 KB

Accession

0001654954-22-015598

Insider Transaction Report

Form 4
Period: 2022-11-18
Oki Mark K
Chief Financial Officer
Transactions
  • Award

    Common Shares

    2022-11-18$0.23/sh+90,000$20,700190,000 total

Issuer

AYTU BIOPHARMA, INC

CIK 0001385818

Entity typeother

Related Parties

1
  • filerCIK 0001491847

Filing Metadata

Form type
4
Filed
Nov 20, 7:00 PM ET
Accepted
Nov 21, 9:30 AM ET
Size
4.4 KB